[HTML][HTML] Factor V Leiden thrombophilia
JL Kujovich - 2018 - europepmc.org
Factor V Leiden thrombophilia is characterized by a poor anticoagulant response to
activated protein C (APC) and an increased risk for venous thromboembolism (VTE). Deep …
activated protein C (APC) and an increased risk for venous thromboembolism (VTE). Deep …
Are natural estrogens used in contraception at lower risk of venous thromboembolism than synthetic ones? A systematic literature review and meta-analysis
J Douxfils, L Raskin, M Didembourg, N Donis… - Frontiers in …, 2024 - frontiersin.org
Background Venous thromboembolism (VTE) poses a significant global health challenge,
notably exacerbated by the use of combined oral contraceptives (COCs). Evidence mainly …
notably exacerbated by the use of combined oral contraceptives (COCs). Evidence mainly …
Reproductive factors, genetic susceptibility and risk of type 2 diabetes: A prospective cohort study
G Fan, Q Liu, J Bi, X Qin, Q Fang, F Luo, X Huang… - Diabetes & …, 2024 - Elsevier
Aim To explore the relationships of multiple reproductive factors with type 2 diabetes mellitus
(T2DM) risk and the joint effects of reproductive factors and genetic susceptibility. Methods …
(T2DM) risk and the joint effects of reproductive factors and genetic susceptibility. Methods …
Genome-wide investigation of exogenous female hormones, genetic variation, and venous thromboembolism risk
EK Hasser, JA Brody, TM Bartz, F Thibord… - Journal of Thrombosis …, 2024 - Elsevier
Background Increased risk of venous thromboembolism (VTE) is a life-threatening side
effect for users of oral contraceptives (OCs) or hormone therapy (HT). Objectives To …
effect for users of oral contraceptives (OCs) or hormone therapy (HT). Objectives To …
[PDF][PDF] Prediction of venous thromboembolism in average-risk, young candidates for oral contraceptive use: to genotype, or not to genotype, that is the question
Conflicts of interest: 26 P. Ve. is Associate Editor of Human Reproduction Open, and a
member of the Editorial Board 27 of the Journal of Obstetrics and Gynaecology Canada and …
member of the Editorial Board 27 of the Journal of Obstetrics and Gynaecology Canada and …
Genetic risk assessment can identify women with high venous thromboembolism risk contributing to precision medicine and personalised care
N Chowdhury, TC Turin - Evidence-Based Nursing, 2024 - ebn.bmj.com
Methods The study included 244 420 female participants from the UK Biobank, recruited
between 2006 and 2010, aged 37–72 years. Baseline information and biological samples …
between 2006 and 2010, aged 37–72 years. Baseline information and biological samples …
The effect of hormonal contraceptives in health status of Sudanese women in Omdurman Locality-Sudan
AAA Idris, HAAA AlRahman, MAE Khalil… - Discover Public …, 2024 - Springer
Background Studies concerning the negative effect of hormonal contraceptives is scarce
and scanty. The main aim of this study the common health problems related to the intake of …
and scanty. The main aim of this study the common health problems related to the intake of …
[HTML][HTML] Factor V Leiden Thrombophilia Synonym: Hereditary Resistance to Activated Protein C
D Pastori, D Menichelli, E Valeriani, P Pignatelli - europepmc.org
Factor V Leiden thrombophilia is characterized by venous thromboembolism (VTE)
manifesting most commonly in adults as deep vein thrombosis (DVT) in the legs or …
manifesting most commonly in adults as deep vein thrombosis (DVT) in the legs or …
[HTML][HTML] Factor V Leiden Thrombophilia
D Pastori, D Menichelli, E Valeriani… - GeneReviews® …, 2024 - ncbi.nlm.nih.gov
Factor V Leiden thrombophilia is characterized by venous thromboembolism (VTE)
manifesting most commonly in adults as deep vein thrombosis (DVT) in the legs or …
manifesting most commonly in adults as deep vein thrombosis (DVT) in the legs or …
[引用][C] Genotyping oral contraceptive users for venous thromboembolism risk
VL Faro, Å Johansson - American Journal of Obstetrics & Gynecology, 2024 - ajog.org
We thank Vercellini and colleagues for their reflections on our study" The risk of venous 29
thromboembolism in oral contraceptive users: the role of genetic factors-a prospective 30 …
thromboembolism in oral contraceptive users: the role of genetic factors-a prospective 30 …